Is Basaglar (insulin glargine) KwikPen 20 units subcutaneously (SQ) at bedtime and a sliding scale of Humalog (insulin lispro) KwikPen 12 units SQ with a hemoglobin A1c (HbA1c) level of 11 sufficient for a 223-pound patient with type 2 diabetes mellitus (DM)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Current Insulin Regimen is Grossly Insufficient for HbA1c of 11%

This patient requires immediate and aggressive insulin intensification—the current regimen of Basaglar 20 units at bedtime with sliding scale Humalog 12 units is completely inadequate for an HbA1c of 11% in a 223-pound (101 kg) patient. 1

Critical Problems with Current Regimen

Basal Insulin Dose is Severely Inadequate

  • At 223 pounds (101 kg), this patient is receiving only 0.2 units/kg/day of basal insulin, which is at the absolute minimum starting dose for insulin-naive patients 1, 2
  • For an HbA1c of 11%, guidelines recommend starting doses of 0.3-0.5 units/kg/day as total daily insulin (both basal and prandial combined), meaning this patient needs 30-50 units/day total, not just 20 units of basal insulin 1, 2
  • The basal insulin should be aggressively titrated by 4 units every 3 days until fasting glucose reaches 80-130 mg/dL 2, 3

Sliding Scale Insulin Alone is Condemned by Guidelines

  • Sliding scale insulin as monotherapy is explicitly condemned by all major diabetes guidelines and shown to be ineffective 1
  • Sliding scale insulin treats hyperglycemia reactively after it occurs rather than preventing it, leading to dangerous glucose fluctuations 1
  • Studies demonstrate that only 38% of patients achieve glucose control <140 mg/dL with sliding scale alone versus 68% with basal-bolus therapy 1, 4

This Patient Requires Basal-Bolus Therapy Immediately

  • With HbA1c ≥10%, patients require immediate basal-bolus insulin therapy, not basal insulin with sliding scale 1, 2, 3
  • The 12 units of Humalog should be converted from reactive sliding scale to scheduled prandial insulin before meals 1

Recommended Insulin Regimen

Immediate Basal Insulin Adjustment

  • Increase Basaglar to at least 30-40 units at bedtime (0.3-0.4 units/kg/day) given the severe hyperglycemia 2, 3
  • Titrate by 4 units every 3 days until fasting glucose consistently reaches 80-130 mg/dL 2, 3
  • Continue titration without arbitrary dose limits—when basal insulin exceeds 0.5 units/kg/day (approximately 50 units), focus shifts to intensifying prandial coverage rather than further basal escalation 1, 2

Convert to Scheduled Prandial Insulin

  • Start with 4 units of Humalog before the largest meal, or use 10% of the basal dose (initially 3-4 units) 1, 2, 3
  • Add prandial insulin before additional meals sequentially based on postprandial glucose patterns 2, 3
  • Titrate prandial doses by 1-2 units or 10-15% twice weekly based on 2-hour postprandial glucose readings 2, 3
  • Maintain correction insulin (sliding scale) as a supplement to scheduled insulin, not as replacement 1

Foundation Therapy

  • Ensure metformin is continued at maximum tolerated dose (at least 2000 mg/day) unless contraindicated 1, 2, 3
  • Metformin reduces total insulin requirements and provides complementary glucose-lowering effects 2, 3

Critical Monitoring Requirements

  • Daily fasting blood glucose monitoring is essential during titration 2, 3
  • Check HbA1c every 3 months during intensive titration 2
  • Monitor for hypoglycemia, especially 2-4 hours after prandial insulin doses 3
  • Reassess regimen every 3-6 months to avoid therapeutic inertia 2

Common Pitfalls to Avoid

  • Delaying insulin intensification while HbA1c remains >10% significantly increases complication risk 2, 3
  • Continuing to rely on sliding scale insulin alone when scheduled basal-bolus therapy is clearly indicated 1
  • Failing to titrate basal insulin aggressively enough—4-unit increments every 3 days are appropriate for HbA1c >10% 2, 3
  • Not adding prandial insulin when basal insulin alone fails to achieve targets after 3-6 months 1, 2

Expected Outcomes with Proper Intensification

  • With appropriate basal-bolus therapy at weight-based dosing (0.4-0.5 units/kg/day total), 68% of patients achieve mean blood glucose <140 mg/dL versus only 38% with sliding scale alone 1, 4
  • HbA1c reduction of 2-3% is achievable with proper insulin intensification from current levels 2, 3
  • No increased hypoglycemia risk with basal-bolus versus sliding scale when properly implemented 1, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Insulin Intensification for Patients with Elevated A1c

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Is a regimen of Basaglar (insulin glargine) KwikPen 20 units subcutaneously (SQ) at bedtime and a sliding scale of Humalog (insulin lispro) KwikPen 12 units SQ before each meal sufficient for a 223-pound patient with type 2 diabetes mellitus (DM) and an Hemoglobin A1c (HbA1c) level of 11?
Is basal-bolus insulin or insulin infusion preferred for non-critically ill hospitalized patients with hyperglycemia?
What is the most appropriate adjustment to improve glycemic control in a patient with type 2 diabetes mellitus and elevated post-dinner glucose levels?
What is the recommended dosing adjustment for sliding scale insulin (lispro) in patients with hyperglycemia?
What insulin adjustment is recommended for a diabetes patient experiencing hypoglycemia (low blood sugar) with noon glucose levels around 2 mmol/L, currently taking 5 units of short-acting insulin (regular insulin) with breakfast, 7 units with lunch, and 7 units with supper?
Can a person have both low serum iron and low Total Iron Binding Capacity (TIBC)?
What is the recommended treatment for a 16-month-old patient presenting with croup?
What is the differential diagnosis for a patient with a calcified granuloma in the liver and moderate ascites, possibly with a history of tuberculosis or histoplasmosis?
What is the appropriate dose of ceftriaxone (Ceftriaxone) for an adult patient with normal renal function and a mild to moderate infection versus a severe infection, such as meningitis or sepsis?
What is the inotrope of choice for a patient with Acute Coronary Syndrome (ACS) Non-ST-Elevation Myocardial Infarction (NSTEMI)?
Is prenatal carrier screening for cystic fibrosis, spinal muscular atrophy, and hemoglobinopathies, as well as aneuploidy testing and 22Q11.2 deletion testing, medically indicated for a 32-year-old pregnant female with a singleton pregnancy and no relevant medical history?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.